Blindness News and Research

RSS

'African eye worm' hampers efforts to eliminate river blindness, study shows

Efforts to eliminate river blindness, a debilitating disease affecting millions in Africa, will be hampered by another parasitic infection known as Loiasis, or 'African eye worm,' according to a study published in Clinical Infectious Diseases.

20 Nov 2019

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

19 Nov 2019

Study of 'face blindness' provides clues to what goes wrong in the brain

People with prosopagnosia, or "face blindness," have trouble recognizing faces -- even those of close friends and family members.

19 Nov 2019

WHO announces two-year scheme to drive down the price of insulin

The World Health Organization plans to make insulin more affordable for the millions of people suffering from diabetes.

18 Nov 2019

Ramping up the body's waste disposal system helps heal diabetics' blood vessels

Research published today in Experimental Physiology shows that ramping up one of the body's waste disposal system, called autophagy, helps heal the blood vessels of diabetics.

17 Nov 2019

Nutraceuticals could help prevent diabetes

Diabetes mellitus is among the fastest-growing conditions in the world, and in Australia, a new case is diagnosed every 5 minutes. Many people with this illness are now taking diet supplements in an attempt to prevent this condition.

17 Nov 2019

Study shows importance of targeted antibody treatment for patients with wet macular degeneration

Wet age-related macular degeneration is one of the leading causes of blindness in the U.S. Breakthrough treatments come with a steep price tag and treatment burden for the patient, but a new study suggests their benefits to patient health and society top billions of dollars, or more, if adherence could be improved.

15 Nov 2019

Survey highlights the need to better educate people on risk factors of type 2 diabetes

Merck, a leading science and technology company, today released the results of research that has shown a lack of knowledge about the risk factors associated with type 2 diabetes internationally.

15 Nov 2019

Improved method for predicting retinopathy of prematurity could reduce unnecessary tests

A multicenter group of 41 hospitals led by researchers at Children's Hospital of Philadelphia (CHOP) has confirmed that an improved method for predicting retinopathy of prematurity (ROP), a leading cause of blindness in children, was able to reduce the number of babies having invasive diagnostic examinations by nearly a third, while raising disease detection up to 100 percent.

14 Nov 2019

Understanding how pressure is regulated in the eye could lead to new treatments for glaucoma

Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye.

14 Nov 2019

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

14 Nov 2019

Fight for Sight funds new project to create UK’s first large-scale glaucoma biobank

Fight for Sight is funding a project to create the UK’s first large-scale glaucoma biobank, a new tool that will help personalize glaucoma treatment and identify patients most at risk of sight loss.

14 Nov 2019

Study examines efficacy of nutraceuticals to manage diabetes

Every five minutes, someone in Australia is diagnosed with diabetes. It’s Australia’s fastest growing chronic condition, but as its prevalence grows more people are adding dietary supplements to their diets in the hope of reducing their risk of the disease.

14 Nov 2019

Age-related macular degeneration (AMD) may affect 77 million Europeans by 2050

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in adults who are more than 50. A new study revealed that the condition might affect 77 million Europeans come 2050.

12 Nov 2019

CRIPSR could be used to detect disease

CRISPR could be used to establish new diagnostic blood tests by identifying viral nucleic acids, such as Parvo or HPV.

11 Nov 2019

Fight for Sight-funded research identifies potential alternative to treat corneal infections, sight loss

A researcher from the University of Nottingham has discovered a possible alternative to traditional anitbiotics to treat corneal infections.

8 Nov 2019

Researchers join forces to adapt novel genetic tool for zoonotic Chlamydia

The human pathogenic bacterium Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen worldwide.

7 Nov 2019

Gene-editing technique CRISPR trialed for first time as cancer treatment

The go-ahead has been given for the first trials using CRISPR as an alternative therapy for treating cancer.

6 Nov 2019

New imaging methods provide unprecedented close-up view of cilia linked to blindness

A new study published today by researchers from Baylor College of Medicine and UT Health's McGovern Medical School in the Proceedings of the National Academy of Sciences reveals an unprecedented close-up view of cilia linked to blindness.

5 Nov 2019

Novel detection method for retinoblastoma

A retinoblastoma is a dangerous cancer often occurring in very young children, under 2, which can cause blindness or the loss of the eye. The tumor is a diffuse, gluey mass spread all over the eye. It also spreads easily. As a result of this, direct biopsy is impossible, unlike with most other tumors. Instead, eye examination by ophthalmologists (eye specialists) and ultrasound imaging are needed to make a diagnosis.

5 Nov 2019

Blindness News and Research

'African eye worm' hampers efforts to eliminate river blindness, study shows

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

Study of 'face blindness' provides clues to what goes wrong in the brain

WHO announces two-year scheme to drive down the price of insulin

Ramping up the body's waste disposal system helps heal diabetics' blood vessels

Nutraceuticals could help prevent diabetes

Study shows importance of targeted antibody treatment for patients with wet macular degeneration

Survey highlights the need to better educate people on risk factors of type 2 diabetes

Improved method for predicting retinopathy of prematurity could reduce unnecessary tests

Understanding how pressure is regulated in the eye could lead to new treatments for glaucoma

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Fight for Sight funds new project to create UK’s first large-scale glaucoma biobank

Study examines efficacy of nutraceuticals to manage diabetes

Age-related macular degeneration (AMD) may affect 77 million Europeans by 2050

CRIPSR could be used to detect disease

Fight for Sight-funded research identifies potential alternative to treat corneal infections, sight loss

Researchers join forces to adapt novel genetic tool for zoonotic Chlamydia

Gene-editing technique CRISPR trialed for first time as cancer treatment

New imaging methods provide unprecedented close-up view of cilia linked to blindness

Novel detection method for retinoblastoma

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News